Inspiration Biopharmaceuticals Treats First Patient In Pivotal Study Of OBI-1 For Acquired Hemophilia A
Links shared publicly online about this topic.
- 713total visits
Inspiration Biopharmaceuticals Treats First Patient In Pivotal Study Of OBI-1 For Acquired Hemophilia A
Inspiration Biopharmaceuticals, Inc. (Inspiration) announced the Company has initiated treatment of patients in a pivotal clinical study of OBI-1, an intravenous recombinant porcine factor VIII (F
View full resource at medicalnewstoday.com
Tags: Hemophilia
Most Recently Shared on November 20, 2010 at 5:05 pm By:
Inspiration Biopharmaceuticals Treats First Patient In Pivotal Study Of OBI-1 For Acquired Hemophilia A http://mnt.to/3MXc #clinicaltrials
Also Shared By:
Advertisement
MNT Blood
@mnt_blood
Inspiration Biopharmaceuticals Treats First Patient In Pivotal Study Of OBI-1 For Acquired Hemophilia A http://mnt.to/3MXc
1 year ago...